(LDL) by the LDL receptor. 2 When excess cholesterol accumulates, cholesterol synthesis is repressed and the number of LDL receptors is downregulated, thereby decreasing the internalization of LDL. Because LDL receptor activity is tightly coupled to the amount of free cholesterol in cells, it is likely that a pathway distinct from LDL receptor-mediated endocytosis is responsible for the pathological accumulation of cholesterol.
(LDL) by the LDL receptor. 2 When excess cholesterol accumulates, cholesterol synthesis is repressed and the number of LDL receptors is downregulated, thereby decreasing the internalization of LDL. Because LDL receptor activity is tightly coupled to the amount of free cholesterol in cells, it is likely that a pathway distinct from LDL receptor-mediated endocytosis is responsible for the pathological accumulation of cholesterol. Apolipoprotein B-100 is the ligand for the binding of LDL to its receptor. 2 When the lysine residues of apolipoprotein B-100 are acetylated, LDL receptor recognition is lost. 1 receptor, 2 endocytosis of lipoproteins by the scavenger receptor is not regulated by cellular cholesterol content, 1 -3 representing a potential pathway for foam cell formation.
The phagocytosis of invading microorganisms and particulate antigens plays a pivotal role in macrophage biology. 8 Yet phagocytosis has been little studied as a possible means for cholesterol deposition during atherogenesis. When LDL is vortexed or complexed with proteoglycans, it aggregates 9 -12 ; such aggregates stimulate macrophage lipid accumulation. Vortexed LDL is taken up by phagocytosis and rapidly degraded, releasing free cholesterol that promotes cholesteryl ester synthesis. 9 In contrast, complexes composed of LDL, heparin, fibronectin, and denatured collagen are poorly degraded by mouse peritoneal macrophages. 10 - 12 The cytoplasm of macrophages exposed to these insoluble particulates exhibits membrane-limited vacuoles that contain flocculent material resembling LDL-proteoglycan complexes, 1012 suggesting that the lipoprotein remains intact after ingestion. These vacuoles bear little resemblance to the cholesteryl ester droplets observed in lipid-laden foam cells.
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When LDL is digested with phospholipase C (phospholipase C-modified LDL; PLC-LDL) to selectively remove the polar moiety of the phospholipid, it is depleted of phosphorus and forms aggregates, probably by hydrophobic interactions. 14 Phagocytic human, rabbit, and mouse macrophages but not monkey smooth muscle cells, bovine aortic endothelial cells, and human skin fibroblasts internalize and degrade 125 I-PLC-LDL.
14 By electron microscopy, mouse macrophages have been observed phagocytosing aggregated lipoprotein. The uptake of PLC-LDL is blocked by a monoclonal antibody that recognizes the ligand-binding domain of the LDL receptor. 14 These results indicate that macrophages internalize PLC-LDL by LDL receptor-dependent phagocytosis.
In this report we investigate the cellular fate of PLC-LDL. Our investigations show that macrophages incubated with PLC-LDL rapidly degraded the lipoprotein in lysosomes, releasing free cholesterol that stimulated cholesteryl ester synthesis. Morphologically, the macrophages exhibited numerous cytoplasmic inclusions that mimic those found in foam cells, suggesting that phagocytosis of lipoprotein aggregates may play a role in atherogenesis.
Methods

Materials
Minicolumns, Sephadex G-50, and Ficoll-Paque were supplied by Pharmacia Fine Chemicals, Piscataway, NJ. Dulbecco's modified Eagle's medium, RPMI-1640, fetal calf serum (heated at 56°C for 30 minutes), trypsin, penicillin, streptomycin, and L-glutamine were obtained from GIBCO 19 Acetylation was confirmed by agarose gel electrophoresis. Protein was measured by the method of Lowry et al 20 with bovine serum albumin as the standard. Lipoprotein concentrations are expressed as micrograms protein per milliliter.
Modification of low density lipoprotein by phospholipase C. The stock solution of phospholipase C (phosphatidylcholine cholinehydrolase, EC 3.1.4.3) was adjusted to 100 units/ml with Tris buffer (50 mM tris[hydroxymethyl]aminomethane HC1, pH 7.4). After dialysis of the enzyme for 12 hours at 4°C against Tris buffer, LDL (final concentration: 1-3 mg/ml) was incubated with 1 unit/ml phospholipase C in Tris buffer for 1 hour at 37°C in a 12x75-mm borosilicate glass tube, then reisolated by passage over a G-50 Sephadex minicolumn (10 cm x 2 cm 2 ) equilibrated with RPMI-1640, and immediately used for experiments. 14 The total cholesterol, cholesteryl ester, triglyceride, and phospholipid compositions of PLC-LDL and LDL were measured as described. 14 Cell culture. Human monocyte-derived macrophages were prepared from the blood of fasting normolipidemic subjects by density gradient centrifugation by the method of Boyum.
21 Plasma (20 ml) anticoagulated with sodium heparin (final concentration: 10 units/ml) was layered over 15 ml FicollPaque. After centrifugation at 500g for 30 minutes at 23°C, the mixed mononuclear cell band was removed by aspiration, and the cells were washed twice at 4°C in RPMI-1640 medium supplemented with L-glutamine (final concentration: 4 mM), 100 units/ml penicillin, and 100 jig/ml streptomycin. The cells were plated either at 3X10 5 monocytes/16-mm dish (Primaria Brand, Falcon Labware) or at 1x10* monocytes/35-mm dish in the same medium containing 20% autologous serum. After 2 hours of incubation at 37°C in 5% CO 2 /95% air, nonadherent cells were removed by three washes with serum-free medium. The cells were placed in fresh medium containing by guest on October 30, 2017 http://atvb.ahajournals.org/ Downloaded from 20% autologous serum, fed twice weekly, and used for experiments after 10-14 days in culture.
Resident mouse peritoneal macrophages were prepared from unstimulated Swiss Webster mice (25-35 g ) by the method of Edelson and Cohn. 22 After one wash at 4°C with Dulbecco's modified Eagle's medium, 1x10* macrophages were plated per 16-mm dish (Falcon 3046, Falcon Labware) in Dulbecco's modified Eagle's medium supplemented with 20% fetal calf serum, 100 units/ml penicillin, and 100
.g/ml streptomycin. After 2 hours of incubation at 37°C in 5% CO 2 /95% air, the cells were washed three times with serum-free medium, refed with medium containing fetal calf serum, and used for experiments the next day. For oil red O staining, 3x10* mouse macrophages were plated on sterile glass coverslips in a 35-mm dish, washed, and cultured as described above.
Metabolism of lipoproteins by cells.
After incubation of macrophages (35-mm dish) with 1 ml serum-free medium supplemented with 125 I-PLC-LDL at the indicated final concentration, cell-associated radioactivity and sterols were quantified as follows. The macrophages were placed on ice and washed three times with 3 ml ice-cold phosphate-buffered saline (PBS) containing 0.2% bovine serum albumin (essentially fatty-acid free) followed by three washes with PBS. To remove cell-surface-bound 125 I-lipoprotein, 23 the cells were incubated for 20 minutes on ice with 3 ml protease buffer (trypsin [4 mg/ml] and EDTA [1 mM] in PBS) and washed twice with PBS. Total cellular lipids were extracted with n-hexane/ isopropanol (3:2, vol/vol), and free cholesterol and cholesteryl ester contents were determined by a fluorescent enzymatic method. 24 The extracted cells were solubilized with 1 ml 0.1M NaOH for 1 hour, and aliquots of the sample were either counted for Oil red O staining. After incubation under the conditions specified, mouse macrophages plated on glass coverslips were washed three times with PBS, fixed with 2% glutaraldehyde, and then immersed in a freshly diluted and filtered oil red O solution (saturated oil red O in isopropanol/water, 6:4, vol/vol). 27 After 5 minutes, the coverslips were rinsed in isopropanol, washed with PBS, and mounted in glycerol.
Transmission electron microscopy. Monolayers of mouse macrophages were washed three times with PBS and fixed in situ with 3% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3) containing 1 mM CaCl 2 and 6% sucrose for 30 minutes at 23°C. The cells were then washed in the same buffer without glutaraldehyde and postfixed with 1% O,O 4 in 0.1 M cacodylate buffer containing 1 mM CaCl 2 for 30 minutes at 23°C. After one wash with 0.1 M cacodylate and three washes with distilled water, the cells were dehydrated with successive washes containing increasing concentrations of ethanol, stained with 3% uranyl acetate in 70% ethanol, washed three times with absolute ethanol, and infiltrated with Epon. Cross sections of the monolayers were then poststained with uranyl acetate and lead citrate before examination with a JEOL 100B electron microscope at an accelerating potential of 60 kV.
Results
Previously, we have shown that depletion of LDL phospholipids by digestion with phospholipase C 28 induces reversible lipoprotein aggregation; the loss of phospholipid parallels the aggregation of PLC-LDL.
14 Phospholipase C at 1 unit/ml induces maximal release of inorganic phosphate from LDL. 14 Under these conditions, approximately 70% of PLC-LDL phospholipid was hydrolyzed relative to LDL ( Table 1) . The other lipid components of PLC-LDL were little affected (Table 1) .
To define biochemically the cellular fate of PLC-LDL, we performed pulse-chase experiments with human monocyte-derived macrophages and then quantified lipoprotein degradation and cell-associated lipoprotein. The cells were first exposed to either 50 or 500 Mg/ml 125 I-PLC-LDL in serum-free medium, followed by a chase period in serum-free medium lacking lipoproteins and acceptors for free cholesterol.
During the pulse incubation with 500 ^g/ml 125 I-PLC-LDL, lipoprotein degradation and cell-associated radioactivity increased linearly ( Figure 1A ). After 8 hours of incubation with Low density lipoprotein (LDL) (1.5 rag/ml) in 50 mM tris(hydroxymethyl)aminomethane buffer (pH 7.4) was incubated for 1 hour at 37°C in the absence (LDL) or presence (PLC-LDL) of 1 unit/ml phospholipase C. Each lipoprotein was reisolated by passage over a Sephadex G-50 minicolumn, an aliquot of the solution was removed for protein determination, and the remainder was extracted with chloroform/methanol for analysis of lipid and phosphorus composition as described in "Methods." Values are mean±SD of triplicate determinations.
PLC-LDL had undergone proteolytic degradation. 29 The uptake of 125 I-PLC-LDL was temperature dependent. At 4°C, human macrophages neither internalized nor degraded 125 I-PLC-LDL. To determine if lower concentrations of PLC-LDL resulted in similar biochemical changes, macrophages were incubated with 50 ^.g/ml lipoprotein for longer periods of time. During a 48-hour exposure to 125 I-PLC-LDL, the uptake and degradation of lipoprotein was initially rapid but then gradually decreased (Figure 2A ). At the end of the pulse, the cells had degraded 33 \ig PLC-LDL/mg cell protein, while little fe I-PLC-LDL remained cell associated. During the chase, all of the cell-associated 123 Ilipoprotein was degraded. Thus, when human monocyte-derived macrophages were exposed to 12i I-PLC-LDL either at low concentrations for prolonged periods or at high concentrations for short periods of time, large amounts of lipoprotein were internalized and degraded. Even at high concentrations of PLC-LDL, the cells failed to accumulate 125 I-lipoprotein aggregates in a compartment that was inaccessible to subsequent proteolysis.
In parallel pulse-chase experiments, we quantified the accumulation of sterol mass in human macrophages. During exposure to 500 Aig/ml PLC-LDL, free cholesterol rapidly increased to levels twice those initially observed when the cells were cultured in 20% autologous serum ( Figure IB) . Cholesteryl ester accumulated even more dramatically: by the end of the pulse incubation, cholesteryl ester had increased 50-fold. After 8 hours, the total sterol mass was 122 Atg/mg cell protein, and half of this was free cholesterol. During the chase period in lipoproteinfree medium, total cellular cholesterol remained approximately constant; most of the free cholesterol that had accumulated underwent esterification. At 50 /xg/ml PLC-LDL similar results were observed, although the increases in free and esterified cholesterol mass were smaller ( Figure 2B ). Even at this low concentration of PLC-LDL, the macrophages exhibited a 30-fold increase in cholesteryl ester. At both the low and high concentrations of PLC-LDL, the Human macrophages cultured in 20% autologous serum were washed twice with serum-free medium and incubated under the indicated conditions: control, medium supplemented with 10% autologous serum; downregulated, medium supplemented with 50 /ig/ml acetylated low density lipoprotein (LDL) and 10% lipoprotein-deficient serum; upregulated, medium supplemented with 10% lipoprotein-deficient serum. After a 24-hour incubation, cells were washed twice with serum-free medium. Each 16-rrun dish of macrophages then received 0.5 ml 125 I-lipoprotein (10 /ig/ml) for 5 hours, and l25 I-lipoprotein degradation products were determined as described in "Methods." Values represent mean±SD of triplicate determinations. PLC, phospholipase C-modified.
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I-PLC-LDL degradation was observed (Table 2) . Thus, changes in LDL receptor number alter the phagocytosis of PLC-LDL. We do not know if other factors also influence the uptake of PLC-LDL by macrophages; such factors might include changes in the state of aggregation of PLC-LDL (which is reversible), apolipoprotein B-100 degradation by macrophage-derived proteases, or variation in the phagocytic ability of human macrophages from different donors.
The lysosomal degradation of LDL releases free cholesterol that is reesterified, thereby increasing the incorporation of [ (Table 3) and mouse ( (Table 3) .
Chloroquine, a weak base that prevents the acidification of lysosomes, inhibits the proteolysis of LDL and acetylated LDL by mouse macrophages. Macrophages were incubated with 250 ng/ml of the indicated lipoprotein, with or without chloroquine (75 /tM), as described in the footnote to Table 3 . After 5 hours of incubation, cells were washed and extracted with hexane/isopropanol (3:2, vol/vol) for determination of [ (Table 4) . These results indicate that PLC-LDL ingested by macrophages underwent lysosomal degradation, thus releasing free cholesterol that was subsequently reesterified.
By light microscopy, mouse and human macrophages incubated with serum-free medium supplemented with 500 /xg/ml PLC-LDL for 12 hours exhibited numerous cytoplasmic inclusions, resembling the foam cells of atherosclerotic lesions. 13 Oil red O stained the inclusions (data not shown), indicating that they contained neutral lipid. Macrophages incubated with acetylated LDL had few oil red O -positive inclusions; inclusions were rarely observed in cells exposed to LDL.
In mouse peritoneal macrophages incubated with PLC-LDL (500 jig/ml) for 12 hours, cytoplasmic inclusions lacking a tripartite membrane were observed by electron microscopy ( Figure 3C ). Membrane-bounded vacuoles also were present: they contained either particulate material or multivesicular bodies.
To establish the relation between the vacuoles and the inclusions, the temporal sequence of their appearance was followed by electron microscopy in mouse macrophages incubated with PLC-LDL (Figure 3) . Before exposure to PLC-LDL, the macrophages rarely exhibited vacuoles or cytoplasmic inclusions ( Figure 3A) . Macrophages briefly incubated with PLC-LDL demonstrated membrane-limited vacuoles filled with particulate matter; this material resembled aggregated lipoprotein and was also observed outside cells exposed to PLC-LDL but not cells exposed to LDL or acetylated LDL. After 6 hours of incubation with PLC-LDL, the macrophages exhibited numerous cytoplasmic vacuoles with a typical tripartite membrane ( Figure 3B ), which contained either particulate matter or multivesicular bodies ( Figures 3B and 4A ). Both membranebounded vacuoles and inclusions were found in macrophages exposed to PLC-LDL for 12 hours ( Figure  3C) ; most of the vacuoles contained multivesicular bodies. After a 12-hour incubation in lipoproteinfree medium (containing no acceptors for free cholesterol), the macrophages had many cytoplasmic inclusions that were not surrounded by a limiting membrane ( Figures 3D and 4B ). Multivesicular bodies filled the few vacuoles present. The cytoplasmic inclusions probably were lipid droplets; they were homogeneously electron dense centrally and were less dense peripherally ( Figure 4B) ; occasionally, electron density was absent. The electron-lucent areas likely represented neutral lipid extracted from the inclusions during fixation of the macrophages. Mouse macrophages exposed to acetylated LDL for longer times have similar electron-dense inclusions. 30 To test the role of cell-surface receptors in mediating the uptake of PLC-LDL, we examined the influence of polyanionic compounds on the degradation of 125 I-PLC-LDL by human monocyte-derived macrophages. Heparin, a sulfated polysaccharide, competes with LDL for binding to its receptor. 31 When human macrophages were incubated with increasing concentrations of heparin, the degradation of 
Discussion
Mouse and human macrophages rapidly ingested and degraded 125 I-PLC-LDL. After only 12 hours of incubation with high concentrations of the aggregated lipoprotein, the cells contained numerous cytoplasmic inclusions that stained with oil red O, indicating that they were neutral lipid droplets. When studied by electron microscopy, membranelimited vacuoles filled with paniculate material appeared initially in the cytoplasm of mouse macrophages exposed to PLC-LDL. These were likely to be phagosomes containing recently ingested lipoprotein. Subsequently, the macrophages exhibited vacuoles laden with multivesicular bodies, presumably partially degraded lipoprotein, that resembled secondary lysosomes. 13 Cytoplasmic inclusions that lacked a tripartite membrane were the last to appear. The inclusions were probably cholesteryl ester lipid droplets derived from hydrolyzed cholesteryl ester and free cholesterol originally present in PLC-LDL.
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Mouse peritoneal macrophages incubated with proteoglycan complexes of LDL accumulate large quantities of lipoprotein. I-lipoprotein/mg remained cell associated. During the chase period, the cell-associated radioactivity underwent proteolysis. Thus, human macrophages ingested large amounts of 125 I-PLC-LDL; rather than remaining intact inside the cells, essentially all of the lipoprotein was degraded.
In human macrophages, the sterol mass derived from internalized PLC-LDL was estimated as the increase in the values of cholesterol and cholesteryl ester during the incubation ( Figures IB and 2B) . These results are in good agreement with the values predicted based on the amount of 125 I-PLC-LDL degraded (compare Figure 1A with Figure IB) , with the assumption that there is 1 /ig lipoprotein cholesterol per microgram lipoprotein protein (Table 1) . After 8 hours of exposure to PLC-LDL, the macrophages exhibited fivefold and 50-fold increases in total sterols and cholesteryl esters, respectively. Cellular free cholesterol had increased twofold; free cholesterol and cholesteryl ester were present in approximately equal amounts. During an ensuing incubation of the macrophages in lipoprotein-free medium, two thirds of the sterol mass was found to be cholesteryl ester. PLC-LDL was also able to stimulate the incorporation of [ u C]oleate into cholesterol [ 14 C]ester. Esterification was blocked by chloroquine, an inhibitor of lysosomal function. Taken together, these results indicate that PLC-LDL phagocytosed by macrophages is subjected to lysosomal degradation, releasing excess free cholesterol, which is esterified by acyl-coenzyme A:cholesterol acyltransferase.
An important question that arises is whether lower concentrations of aggregated lipoprotein could induce similar biochemical changes in macrophages. When human monocyte-derived macrophages were exposed to 50 ^g/ml 125 I-PLC-LDL for 48 hours, total cellular sterol and cholesteryl ester increased twofold and 30-fold, respectively. These results indicate that long-term exposure of the macrophages to lipoprotein aggregates, even at low concentrations, may play a role in pathological lipid accumulation.
We previously have shown that macrophages internalize PLC-LDL by phagocytosis.
14 Phagocytosis requires attachment of a ligand to a cell-surface receptor, followed by ingestion of the bound particle.
phages resemble lipid-laden foam cells, the hallmark of the early atherosclerotic lesion. These results suggest that phagocytosis of lipoprotein aggregates may play a role in the pathological deposition of cholesterol in arterial wall macrophages.
